The lipoprotein profile differs during insulin treatment alone and combination therapy with insulin and sulphonylureas in patients with Type 2 diabetes mellitus.

MLA

Lindström, T., et al. “The Lipoprotein Profile Differs during Insulin Treatment Alone and Combination Therapy with Insulin and Sulphonylureas in Patients with Type 2 Diabetes Mellitus.” Diabetic Medicine, vol. 16, no. 10, Oct. 1999, pp. 820–26. EBSCOhost, https://doi.org/10.1046/j.1464-5491.1999.00170.x.

APA

Lindström, T., Nyström, F. H., Olsson, A. G., Ottosson, A.-M., & Arnqvist, H. J. (1999). The lipoprotein profile differs during insulin treatment alone and combination therapy with insulin and sulphonylureas in patients with Type 2 diabetes mellitus. Diabetic Medicine, 16(10), 820–826. https://doi.org/10.1046/j.1464-5491.1999.00170.x

Chicago

Lindström, T., F. H. Nyström, A. G. Olsson, A. -M. Ottosson, and H. J. Arnqvist. 1999. “The Lipoprotein Profile Differs during Insulin Treatment Alone and Combination Therapy with Insulin and Sulphonylureas in Patients with Type 2 Diabetes Mellitus.” Diabetic Medicine 16 (10): 820–26. doi:10.1046/j.1464-5491.1999.00170.x.